Airfinity launches free obesity market newsletter

Posted on Oct 26, 2023

Current estimates indicate 650 million people are obese globally, and the US alone spends $173 Bn/year in obesity-related healthcare costs. Airfinity forecasts that treating just half of all severely obese patients with metabolic syndrome would generate an $80 Bn market by 2030 in the US, growing more than 30X from today’s $2.2 Bn.

In response to this fast moving landscape, Airfinity has launched a weekly obesity market intelligence newsletter, providing independent analysis, as well as a curated summary of the latest news, commentary, and scientific results delivered to your inbox every week.

Our team of specialised analysts and scientists monitor and assess the entire anti-obesity landscape, spanning hundreds of data sources and channels, in order to get you the most important information and give answers to the critical questions.

Learn more about what is included in the newsletter and how to subscribe here.

To discuss access to Airfinity's independent forecasts and disease modelling, including the impact of anti-obesity drug uptake on cardiovascular outcomes, get in touch here.

More Insights From Airfinity

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases

Oct 10, 2022

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers

Aug 25, 2022

Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir

Jul 25, 2022

COVID-19 vaccines sales to bounce back with new jabs taking a fifth of the 2022 market

Jul 15, 2022

AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination

Jul 13, 2022

Global wastage of COVID-19 vaccines could be 1.1 billion doses

Jul 11, 2022